Autologous Stem Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
99
NCT04042844
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2022
Completion: Dec 31, 2027
Loading map...